These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 17618170)

  • 1. Extina foam (2%).
    Abramovits W; Gupta AK
    Skinmed; 2007; 6(4):186-7. PubMed ID: 17618170
    [No Abstract]   [Full Text] [Related]  

  • 2. Ketoconazole: a review of a workhorse antifungal molecule with a focus on new foam and gel formulations.
    Scheinfeld N
    Drugs Today (Barc); 2008 May; 44(5):369-80. PubMed ID: 18548138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel foam formulation of ketoconazole 2% for the treatment of seborrheic dermatitis on multiple body regions.
    Elewski BE; Abramovits W; Kempers S; Schlessinger J; Rosen T; Gupta AK; Abraham S; Rowell R
    J Drugs Dermatol; 2007 Oct; 6(10):1001-8. PubMed ID: 17966177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ketoconazole foam--connetics: connetics ketoconazole foam.
    Drugs R D; 2003; 4(5):323-5. PubMed ID: 12952504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of ketoconazole in seborrheic dermatitis.
    Borgers M; Degreef H
    Cutis; 2007 Oct; 80(4):359-63. PubMed ID: 18038701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The safety of ketoconazole shampoo for infantile seborrheic dermatitis.
    Brodell RT; Patel S; Venglarcik JS; Moses D; Gemmel D
    Pediatr Dermatol; 1998; 15(5):406-7. PubMed ID: 9796598
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment for seborrheic dermatitis].
    Kupfer-Bessaguet I; Misery L; Plantin P
    Ann Dermatol Venereol; 2004 Nov; 131(11):998. PubMed ID: 15627992
    [No Abstract]   [Full Text] [Related]  

  • 8. Transient band-like keratopathy after treatment for seborrheic dermatitis.
    Savage HI; Edgington B; Appel J
    Cornea; 2005 Apr; 24(3):342-3. PubMed ID: 15778610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomised, single-blind, single-centre clinical trial to evaluate comparative clinical efficacy of shampoos containing ciclopirox olamine (1.5%) and salicylic acid (3%), or ketoconazole (2%, Nizoral) for the treatment of dandruff/seborrhoeic dermatitis.
    Squire RA; Goode K
    J Dermatolog Treat; 2002 Jun; 13(2):51-60. PubMed ID: 12060502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomised double blind controlled trial of 2% ketoconazole cream versus 0.05% clobetasol 17-butyrate cream in seborrhoeic dermatitis.
    Pari T; Pulimood S; Jacob M; George S; Jeyaseelan L; Thomas K
    J Eur Acad Dermatol Venereol; 1998 Jan; 10(1):89-90. PubMed ID: 9552768
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of antifungal agents in the treatment of seborrheic dermatitis.
    Gupta AK; Nicol K; Batra R
    Am J Clin Dermatol; 2004; 5(6):417-22. PubMed ID: 15663338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ketoconazole does not decrease fungal amount in patients with seborrhoeic dermatitis.
    Zani MB; Soares RC; Arruda AC; de Arruda LH; Paulino LC
    Br J Dermatol; 2016 Aug; 175(2):417-21. PubMed ID: 26920094
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term safety of ketoconazole foam, 2% in the treatment of seborrheic dermatitis: results of a phase IV, open-label study.
    Draelos ZD; Feldman SR; Butners V; Alió Saenz AB
    J Drugs Dermatol; 2013 Jan; 12(1):e1-6. PubMed ID: 23377341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical Treatment of Facial Seborrheic Dermatitis: A Systematic Review.
    Gupta AK; Versteeg SG
    Am J Clin Dermatol; 2017 Apr; 18(2):193-213. PubMed ID: 27804089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ketoconazole gel 2% in the treatment of moderate to severe seborrheic dermatitis.
    Swinyer LJ; Decroix J; Langner A; Quiring JN; Blockhuys S
    Cutis; 2007 Jun; 79(6):475-82. PubMed ID: 17713152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allergic contact dermatitis from ketoconazole.
    Liu J; Warshaw EM
    Cutis; 2014 Sep; 94(3):112-4. PubMed ID: 25279470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A red rash on the face.
    Usatine RP
    J Fam Pract; 2003 Sep; 52(9):697-9. PubMed ID: 12967541
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy and safety of a new once-daily topical ketoconazole 2% gel in the treatment of seborrheic dermatitis: a phase III trial.
    Elewski B; Ling MR; Phillips TJ
    J Drugs Dermatol; 2006; 5(7):646-50. PubMed ID: 16865870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of topical 4% Quassia amara gel in facial seborrheic dermatitis:a randomized, double-blind, comparative study.
    Diehl C; Ferrari A
    J Drugs Dermatol; 2013 Mar; 12(3):312-5. PubMed ID: 23545914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seborrheic dermatitis.
    Gupta AK; Bluhm R; Cooper EA; Summerbell RC; Batra R
    Dermatol Clin; 2003 Jul; 21(3):401-12. PubMed ID: 12956195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.